Why retention changes the treatment decision, and which surgical option is actually best suited for it
For men in refractory urinary retention caused by an enlarged prostate (BPH) — retention that doesn't resolve after a trial without catheter, or keeps recurring — guidelines recommend definitive surgical treatment rather than long-term catheterization. Among surgical options, laser enucleation (HoLEP/ThuLEP) is generally the preferred choice: it removes the obstructing tissue completely regardless of prostate size, has one of the highest published success rates for restoring normal voiding in retention patients, and avoids the risk of retention recurring after a 'partial' procedure. Newer minimally invasive techniques (like Rezum) are typically not recommended for men already in retention, since their supporting evidence is mainly in patients who can still void.
Refractory retention means the bladder isn't emptying reliably on its own, and it isn't correcting itself: a failed trial without catheter (the catheter is removed and the patient can't void), retention that recurs after an initial successful trial, or chronic retention with persistently high residual urine despite medication. This is different from one isolated episode — for example, triggered by an infection or certain medications — that resolves cleanly after a single catheterization.
For most men with BPH, bothersome symptoms alone are a relative indication for surgery — meaning medication is a reasonable first step, and surgery is a choice based on how much the symptoms affect quality of life. Refractory retention is different: EAU and AUA guidelines list it as an absolute indication for surgery, alongside recurrent urinary tract infections, bladder stones, recurrent significant bleeding, and kidney impairment from the obstruction. In practice, this means surgery is recommended rather than optional, because continued obstruction and long-term catheterization carry real risks to bladder and kidney health.
Currently managing retention with a catheter? Discuss your surgical options with Dr. Samer Morsy
💬 WhatsApp Dr. MorsyProlonged untreated obstruction can lead to bladder muscle decompensation (the bladder gradually loses its ability to contract effectively), recurrent urinary tract infections, bladder stones from stagnant urine, and — in more severe or prolonged cases — impaired kidney function from back-pressure on the upper urinary tract. This is why refractory retention is treated as a priority rather than something to manage indefinitely with a catheter.
Recovery after laser enucleation for retention follows the same general course as for any BPH laser surgery — the same catheter timeline, temporary side effects, and results. See our full guide on what to expect after BPH laser surgery for the complete recovery timeline.
Refractory urinary retention from BPH is an absolute indication for surgery, not a symptom to manage indefinitely with a catheter. Among the surgical options, laser enucleation (HoLEP/ThuLEP) is generally the best-suited choice for this specific situation — complete, size-independent removal of the obstruction with strong success rates in exactly this patient group.
This article focuses on retention caused by prostate enlargement (BPH), the most common cause in older men. Retention from other causes (e.g. neurogenic bladder, urethral stricture) needs its own separate evaluation.
Ready to take the next step? Book your appointment today
📅 Book Appointment